BRIEF

on EIFFAGE (EPA:FGR)

Eiffage Secures €72 Million Contract for Cancer Centre Expansion in Rouen

Stock price chart of EIFFAGE (EPA:FGR) showing fluctuations.

Eiffage, through its subsidiary Eiffage Construction, has secured a contract with partners Fouchard and Sner to extend and restructure the Henri Becquerel cancer treatment centre in Rouen, France. This significant project, valued at €72 million, designates Eiffage's share at €50 million.

The development includes a new 14,100 m² five-storey building linked to the existing facility by a curved three-storey structure. Upon completion, the site will boast a 16,700 m² floor area, augmented with landscaped areas and parking.

Designed by Group-6, supported by Ingerop, Atelier des Deux Anges, and ARP Astrance, the project prioritizes transparency and eco-efficiency. Large windows will enhance natural light, while sustainable practices include reusing materials and utilizing rainwater management.

Work has commenced with a completion target set for 2026, ensuring uninterrupted patient care during construction.

R. P.

Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all EIFFAGE news